{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:05:18Z","timestamp":1758906318391,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":90,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540938620"},{"type":"electronic","value":"9783540938644"}],"license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-93864-4_11","type":"book-chapter","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T01:44:25Z","timestamp":1241660665000},"page":"265-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiphoton Imaging of Cytotoxic T Lymphocyte-Mediated Antitumor Immune Responses"],"prefix":"10.1007","author":[{"given":"Alexandre","family":"Boissonnas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alix","family":"Scholer-Dahire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Fetler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Amigorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"11_CR1_11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2006.10.011","volume":"25","author":"M Bajenoff","year":"2006","unstructured":"Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN. (2006) Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25:989\u20131001","journal-title":"Immunity"},{"key":"11_CR2_11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.173.3.647","volume":"173","author":"RJ Barth Jr","year":"1991","unstructured":"Barth RJ Jr, Mule JJ, Spiess PJ, Rosenberg SA. (1991) Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med 173:647\u2013658","journal-title":"J Exp Med"},{"key":"11_CR3_11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/eji.200526175","volume":"36","author":"U Blohm","year":"2006","unstructured":"Blohm U, Potthoff D, van der Kogel AJ, Pircher H. (2006) Solid tumors \u201cmelt\u201d from the inside after successful CD8 T cell attack. Eur J Immunol 36:468\u2013477","journal-title":"Eur J Immunol"},{"key":"11_CR4_11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4049\/jimmunol.173.1.222","volume":"173","author":"A Boissonnas","year":"2004","unstructured":"Boissonnas A, Combadiere C, Lavergne E, Maho M, Blanc C, Debre P, Combadiere B. (2004) Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency. J Immunol 173:222\u2013229","journal-title":"J Immunol"},{"key":"11_CR5_11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20061890","volume":"204","author":"A Boissonnas","year":"2007","unstructured":"Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S. (2007) In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 204:345\u2013356","journal-title":"J Exp Med"},{"key":"11_CR6_11","unstructured":"Boissonnas A, Scholer-Dahirel A, Simon-Blancal V, Kissenpfennig A, Sparwasser T, Malissen B, Fetler L, Amigorena S. Regulatory T cells control dendritic cells survival in tumor draining lymph node. (Submitted)"},{"key":"11_CR7_11","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.biochi.2007.04.014","volume":"89","author":"M Bonmort","year":"2007","unstructured":"Bonmort M, Ullrich E, Mignot G, Jacobs B, Chaput N, Zitvogel L. (2007) Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC). Biochimie 89:872\u2013877","journal-title":"Biochimie"},{"key":"11_CR8_11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni1557","volume":"9","author":"P Bousso","year":"2008","unstructured":"Bousso P. (2008) T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 9:155\u2013165","journal-title":"Nat Rev Immunol"},{"key":"11_CR9_11","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI34388","volume":"118","author":"B Breart","year":"2008","unstructured":"Breart B, Lemaitre F, Celli S, Bousso P. (2008) Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 118:1390\u20131397","journal-title":"J Clin Invest"},{"key":"11_CR10_11","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V96.9.3102","volume":"96","author":"P Brossart","year":"2000","unstructured":"Brossart P, Wirths S, Stuhler G, Reichardt VL, Kanz L, Brugger W. (2000) Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96:3102\u20133108","journal-title":"Blood"},{"key":"11_CR11_11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0065-2776(08)60022-X","volume":"72","author":"EC Butcher","year":"1999","unstructured":"Butcher EC, Williams M, Youngman K, Rott L, Briskin M. (1999) Lymphocyte trafficking and regional immunity. Adv Immunol 72:209\u2013253","journal-title":"Adv Immunol"},{"key":"11_CR12_11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4049\/jimmunol.171.5.2187","volume":"171","author":"T Calzascia","year":"2003","unstructured":"Calzascia T, Di Berardino-Besson W, Wilmotte R, Masson F, de Tribolet N, Dietrich PY, Walker PR. (2003) Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain. J Immunol 171:2187\u20132191","journal-title":"J Immunol"},{"key":"11_CR13_11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.immuni.2004.12.008","volume":"22","author":"T Calzascia","year":"2005","unstructured":"Calzascia T, Masson F, Di Berardino-Besson W, Contassot E, Wilmotte R, Aurrand-Lions M, Ruegg C, Dietrich PY, Walker PR. (2005) Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22:175\u2013184","journal-title":"Immunity"},{"key":"11_CR14_11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04651","volume":"440","author":"F Castellino","year":"2006","unstructured":"Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440:890\u2013895","journal-title":"Nature"},{"key":"11_CR15_11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.immuni.2007.08.018","volume":"27","author":"S Celli","year":"2007","unstructured":"Celli S, Lemaitre F, Bousso P. (2007) Real-time manipulation of T cell-dendritic cell interactions in vivo reveals the importance of prolonged contacts for CD4+ T cell activation. Immunity 27:625\u2013634","journal-title":"Immunity"},{"key":"11_CR16_11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00262-003-0425-4","volume":"52","author":"Q Chen","year":"2003","unstructured":"Chen Q, Wang WC, Evans SS. (2003) Tumor microvasculature as a barrier to antitumor immunity. Cancer Immunol Immunother 52:670\u2013679","journal-title":"Cancer Immunol Immunother"},{"key":"11_CR17_11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1073\/pnas.0408197102","volume":"102","author":"ML Chen","year":"2005","unstructured":"Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, Khazaie K. (2005) Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A 102:419\u2013424","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR18_11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/352067a0","volume":"352","author":"ER Christinck","year":"1991","unstructured":"Christinck ER, Luscher MA, Barber BH, Williams DB. (1991) Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352:67\u201370","journal-title":"Nature"},{"key":"11_CR19_11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","volume":"22","author":"A Corthay","year":"2005","unstructured":"Corthay A, Skovseth DK, Lundin KU, Rosjo E, Omholt H, Hofgaard PO, Haraldsen G, Bogen B. (2005) Primary antitumor immune response mediated by CD4+ T cells. Immunity 22:371\u2013383","journal-title":"Immunity"},{"key":"11_CR20_11","first-page":"2322","volume":"63","author":"AE Dirkx","year":"2003","unstructured":"Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J, Griffioen AW. (2003) Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 63:2322\u20132329","journal-title":"Cancer Res"},{"key":"11_CR21_11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/0008-5472.CAN-03-2580","volume":"64","author":"MJ Dobrzanski","year":"2004","unstructured":"Dobrzanski MJ, Reome JB, Hollenbaugh JA, Hylind JC, Dutton RW. (2004) Effector cell-derived lymphotoxin alpha and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases. Cancer Res 64:406\u2013414","journal-title":"Cancer Res"},{"key":"11_CR22_11","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4049\/jimmunol.177.9.6018","volume":"177","author":"BP Dolan","year":"2006a","unstructured":"Dolan BP, Gibbs KD Jr, Ostrand-Rosenberg S. (2006a) Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J Immunol 177:6018\u20136024","journal-title":"J Immunol"},{"key":"11_CR23_11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.176.3.1447","volume":"176","author":"BP Dolan","year":"2006b","unstructured":"Dolan BP, Gibbs KD Jr, Ostrand-Rosenberg S. (2006b) Tumor-specific CD4+ T cells are activated by \u201ccross-dressed\u201d dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J Immunol 176:1447\u20131455","journal-title":"J Immunol"},{"key":"11_CR24_11","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1073\/pnas.0337418100","volume":"100","author":"P Dubey","year":"2003","unstructured":"Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, Gambhir SS, Witte ON. (2003) Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A 100:1232\u20131237","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR25_11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1084\/jem.20042167","volume":"201","author":"AM Ercolini","year":"2005","unstructured":"Ercolini AM, Ladle BH, Manning EA, Pfannenstiel LW, Armstrong TD, Machiels JP, Bieler JG, Emens LA, Reilly RT, Jaffee EM. (2005) Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med 201:1591\u20131602","journal-title":"J Exp Med"},{"key":"11_CR26_11","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1158\/0008-5472.CAN-05-0436","volume":"65","author":"TP Gade","year":"2005","unstructured":"Gade TP, Hassen W, Santos E, Gunset G, Saudemont A, Gong MC, Brentjens R, Zhong XS, Stephan M, Stefanski J, et al. (2005) Targeted elimination of prostate cancer by genetically directed human T lymphocytes. Cancer Res 65:9080\u20139088","journal-title":"Cancer Res"},{"key":"11_CR27_11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.cji.0000199193.29048.56","volume":"29","author":"TF Gajewski","year":"2006","unstructured":"Gajewski TF, Meng Y, Harlin H. (2006) Immune suppression in the tumor microenvironment. J Immunother 29:233\u2013240","journal-title":"J Immunother"},{"key":"11_CR28_11","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1073\/pnas.0610019104","volume":"104","author":"Z Garcia","year":"2007","unstructured":"Garcia Z, Pradelli E, Celli S, Beuneu H, Simon A, Bousso P. (2007) Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion. Proc Natl Acad Sci U S A 104:4553\u20134558","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR29_11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1600-065X.1995.tb00079.x","volume":"145","author":"KE Hellstrom","year":"1995","unstructured":"Hellstrom KE, Hellstrom I, Chen L. (1995) Can co-stimulated tumor immunity be therapeutically efficacious. Immunol Rev 145:123\u2013145","journal-title":"Immunol Rev"},{"key":"11_CR30_11","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.4049\/jimmunol.177.5.3004","volume":"177","author":"JA Hollenbaugh","year":"2006","unstructured":"Hollenbaugh JA, Dutton RW. (2006) IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. J Immunol 177:3004\u20133011","journal-title":"J Immunol"},{"key":"11_CR31_11","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.4049\/jimmunol.173.3.1738","volume":"173","author":"JA Hollenbaugh","year":"2004","unstructured":"Hollenbaugh JA, Reome J, Dobrzanski M, and Dutton RW. (2004) The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis. J Immunol 173:1738\u20131743","journal-title":"J Immunol"},{"key":"11_CR32_11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1084\/jem.183.3.769","volume":"183","author":"AY Huang","year":"1996a","unstructured":"Huang AY, Bruce AT, Pardoll DM, Levitsky HI. (1996a) Does B7\u20131 expression confer antigen-presenting cell capacity to tumors in vivo. J Exp Med 183:769\u2013776","journal-title":"J Exp Med"},{"key":"11_CR33_11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1074-7613(00)80248-4","volume":"4","author":"AY Huang","year":"1996b","unstructured":"Huang AY, Bruce AT, Pardoll DM, Levitsky HI. (1996b) In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4:349\u2013355","journal-title":"Immunity"},{"key":"11_CR34_11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni1134","volume":"5","author":"S Hugues","year":"2004","unstructured":"Hugues S, Fetler L, Bonifaz L, Helft J, Amblard F, Amigorena S. (2004) Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 5:1235\u20131242","journal-title":"Nat Immunol"},{"key":"11_CR35_11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.coi.2006.03.021","volume":"18","author":"S Hugues","year":"2006","unstructured":"Hugues S, Boissonnas A, Amigorena S, Fetler L. (2006) The dynamics of dendritic cell-T cell interactions in priming and tolerance. Curr Opin Immunol 18:491\u2013495","journal-title":"Curr Opin Immunol"},{"key":"11_CR36_11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ni1495","volume":"8","author":"S Hugues","year":"2007","unstructured":"Hugues S, Scholer A, Boissonnas A, Nussbaum A, Combadiere C, Amigorena S, Fetler L. (2007) Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses. Nat Immunol 8:921\u2013930","journal-title":"Nat Immunol"},{"key":"11_CR37_11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1084\/jem.194.11.1549","volume":"194","author":"S Ibe","year":"2001","unstructured":"Ibe S, Qin Z, Schuler T, Preiss S, Blankenstein T. (2001) Tumor rejection by disturbing tumor stroma cell interactions. J Exp Med 194:1549\u20131559","journal-title":"J Exp Med"},{"key":"11_CR38_11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00437472","volume":"15","author":"RK Jain","year":"1996","unstructured":"Jain RK, Koenig GC, Dellian M, Fukumura D, Munn LL, Melder RJ. (1996) Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev 15:195\u2013204","journal-title":"Cancer Metastasis Rev"},{"key":"11_CR39_11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrc778","volume":"2","author":"RK Jain","year":"2002","unstructured":"Jain RK, Munn LL, Fukumura D. (2002) Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2:266\u2013276","journal-title":"Nat Rev Cancer"},{"key":"11_CR40_11","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1158\/0008-5472.CAN-05-3526","volume":"66","author":"NT Joncker","year":"2006a","unstructured":"Joncker NT, Helft J, Jacquet A, Premel V, Lantz O. (2006a) Intratumor CD4 T-cell accumulation requires stronger priming than for expansion and lymphokine secretion. Cancer Res 66:5443\u20135451","journal-title":"Cancer Res"},{"key":"11_CR41_11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ijc.21472","volume":"118","author":"NT Joncker","year":"2006b","unstructured":"Joncker NT, Marloie MA, Chernysheva A, Lonchay C, Cuff S, Klijanienko J, Sigal-Zafrani B, Vincent-Salomon A, Sastre X, Lantz O. (2006b) Antigen-independent accumulation of activated effector\/memory T lymphocytes into human and murine tumors. Int J Cancer 118:1205\u20131214","journal-title":"Int J Cancer"},{"key":"11_CR42_11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.molmed.2005.03.002","volume":"11","author":"T Kammertoens","year":"2005","unstructured":"Kammertoens T, Schuler T, Blankenstein T. (2005) Immunotherapy: target the stroma to hit the tumor. Trends Mol Med 11:225\u2013231","journal-title":"Trends Mol Med"},{"key":"11_CR43_11","first-page":"6838","volume":"63","author":"MF Kircher","year":"2003","unstructured":"Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R. (2003) In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63:6838\u20136846","journal-title":"Cancer Res"},{"key":"11_CR44_11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0008-8749(72)90096-2","volume":"5","author":"E Klein","year":"1972","unstructured":"Klein E, Klein G. (1972) Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells. Cell Immunol 5:201\u2013208","journal-title":"Cell Immunol"},{"key":"11_CR45_11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.7761853","volume":"268","author":"TM Kundig","year":"1995","unstructured":"Kundig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M, Lother H, Gessner A, Kuhlcke K, Ohashi PS, Hengartner H, et al. (1995) Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268:1343\u20131347","journal-title":"Science"},{"key":"11_CR46_11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20041378","volume":"201","author":"C Lurquin","year":"2005","unstructured":"Lurquin C, Lethe B, De Plaen E, Corbiere V, Theate I, van Baren N, Coulie PG, Boon T. (2005) Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen. J Exp Med 201:249\u2013257","journal-title":"J Exp Med"},{"key":"11_CR47_11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. (2008) Cancer-related inflammation. Nature 454:436\u2013444","journal-title":"Nature"},{"key":"11_CR48_11","first-page":"3376","volume":"58","author":"M Maric","year":"1998","unstructured":"Maric M, Zheng P, Sarma S, Guo Y, Liu Y. (1998) Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: a critical role for costimulation by B7 on both tumor and host antigen-presenting cells. Cancer Res 58:3376\u20133384","journal-title":"Cancer Res"},{"key":"11_CR49_11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nature02238","volume":"427","author":"TR Mempel","year":"2004","unstructured":"Mempel TR, Henrickson SE, Von Andrian UH. (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154\u2013159","journal-title":"Nature"},{"key":"11_CR50_11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2006.04.015","volume":"25","author":"TR Mempel","year":"2006","unstructured":"Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, von Boehmer H, von Andrian UH. (2006) Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25:129\u2013141","journal-title":"Immunity"},{"key":"11_CR51_11","first-page":"200","volume":"856","author":"MJ Miller","year":"2004","unstructured":"Miller MJ, Safrina O, Parker I, Cahalan MD (2004) Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med 200:847\u2013856","journal-title":"J Exp Med"},{"key":"11_CR52_11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature01726","volume":"424","author":"JR Mora","year":"2003","unstructured":"Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. (2003) Selective imprinting of gut-homing T cells by Peyer\u2019s patch dendritic cells. Nature 424:88\u201393","journal-title":"Nature"},{"key":"11_CR53_11","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1084\/jem.20060710","volume":"203","author":"P Mrass","year":"2006","unstructured":"Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A, Cavanagh LL, von Andrian UH, Ertl HC, Haydon PG, Weninger W. (2006) Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 203:2749\u20132761","journal-title":"J Exp Med"},{"key":"11_CR54_11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-065X.2006.00433.x","volume":"213","author":"P Mrass","year":"2006","unstructured":"Mrass P, Weninger W. (2006) Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors. Immunol Rev 213:195\u2013212","journal-title":"Immunol Rev"},{"key":"11_CR55_11","first-page":"5245","volume":"59","author":"S Mukai","year":"1999","unstructured":"Mukai S, Kjaergaard J, Shu S, Plautz GE. (1999) Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res 59:5245\u20135249","journal-title":"Cancer Res"},{"key":"11_CR56_11","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1158\/0008-5472.CAN-07-6229","volume":"68","author":"S Nagaraj","year":"2008","unstructured":"Nagaraj S, Gabrilovich DI. (2008) Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res 68:2561\u20132563","journal-title":"Cancer Res"},{"key":"11_CR57_11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1600-065X.2008.00596.x","volume":"221","author":"LG Ng","year":"2008","unstructured":"Ng LG, Mrass P, Kinjyo I, Reiner SL, Weninger W. (2008) Two-photon imaging of effector T-cell behavior: lessons from a tumor model. Immunol Rev 221:147\u2013162","journal-title":"Immunol Rev"},{"key":"11_CR58_11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.coi.2007.01.005","volume":"19","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn F, Ravetch JV. (2007) Antibodies, Fc receptors and cancer. Curr Opin Immunol 19:239\u2013245","journal-title":"Curr Opin Immunol"},{"key":"11_CR59_11","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1073\/pnas.96.5.2233","volume":"96","author":"AF Ochsenbein","year":"1999","unstructured":"Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, Zinkernagel RM. (1999) Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci USA 96:2233\u20132238","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR60_11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/35082583","volume":"411","author":"AF Ochsenbein","year":"2001","unstructured":"Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H, Zinkernagel RM. (2001) Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411:1058\u20131064","journal-title":"Nature"},{"key":"11_CR61_11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00262-005-0109-3","volume":"55","author":"G Pawelec","year":"2006","unstructured":"Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C. (2006) Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother 55:981\u2013986","journal-title":"Cancer Immunol Immunother"},{"key":"11_CR62_11","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.4049\/jimmunol.165.12.7116","volume":"165","author":"L Peng","year":"2000","unstructured":"Peng L, Krauss JC, Plautz GE, Mukai S, Shu S, Cohen PA. (2000) T cell-mediated tumor rejection displays diverse dependence upon perforin and IFN-gamma mechanisms that cannot be predicted from in vitro T cell characteristics. J Immunol 165:7116\u20137124","journal-title":"J Immunol"},{"key":"11_CR63_11","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","volume":"109","author":"A Perez-Diez","year":"2007","unstructured":"Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, Matzinger P. (2007) CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109:5346\u20135354","journal-title":"Blood"},{"key":"11_CR64_11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1074-7613(00)80218-6","volume":"12","author":"Z Qin","year":"2000","unstructured":"Qin Z, Blankenstein T. (2000) CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 12:677\u2013686","journal-title":"Immunity"},{"key":"11_CR65_11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc2355","volume":"8","author":"SA Rosenberg","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8:299\u2013308","journal-title":"Nat Rev Cancer"},{"key":"11_CR66_11","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al. (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538\u201318543","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR67_11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.immuni.2007.12.016","volume":"28","author":"A Scholer","year":"2008","unstructured":"Scholer A, Hugues S, Boissonnas A, Fetler L, Amigorena S. (2008) Intercellular Adhesion Molecule-1-Dependent Stable Interactions between T Cells and Dendritic Cells Determine CD8(+) T Cell Memory. Immunity 28:258\u2013270","journal-title":"Immunity"},{"key":"11_CR68_11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0952-7915(98)80227-6","volume":"10","author":"S Shresta","year":"1998","unstructured":"Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. (1998) How do cytotoxic lymphocytes kill their targets. Curr Opin Immunol 10:581\u2013587","journal-title":"Curr Opin Immunol"},{"key":"11_CR69_11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ni1490","volume":"8","author":"D Skokos","year":"2007","unstructured":"Skokos D, Shakhar G, Varma R, Waite JC, Cameron TO, Lindquist RL, Schwickert T, Nussenzweig MC, Dustin ML. (2007) Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat Immunol 8:835\u2013844","journal-title":"Nat Immunol"},{"key":"11_CR70_11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mrm.20996","volume":"56","author":"P Smirnov","year":"2006","unstructured":"Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, Doan BT, Gillet B, Combadiere C, Combadiere B, Clement O. (2006) In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn Reson Med 56:498\u2013508","journal-title":"Magn Reson Med"},{"key":"11_CR71_11","first-page":"5267","volume":"62","author":"R Somasundaram","year":"2002","unstructured":"Somasundaram R, Jacob L, Swoboda R, Caputo L, Song H, Basak S, Monos D, Peritt D, Marincola F, Cai D, et al. (2002) Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+\/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res 62:5267\u20135272","journal-title":"Cancer Res"},{"key":"11_CR72_11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1074-7613(02)00480-6","volume":"17","author":"MT Spiotto","year":"2002","unstructured":"Spiotto MT, Yu P, Rowley DA, Nishimura MI, Meredith SC, Gajewski TF, Fu YX, Schreiber H. (2002) Increasing tumor antigen expression overcomes \u201cignorance\u201d to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 17:737\u2013747","journal-title":"Immunity"},{"key":"11_CR73_11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nm999","volume":"10","author":"MT Spiotto","year":"2004","unstructured":"Spiotto MT, Rowley DA, Schreiber H. (2004) Bystander elimination of antigen loss variants in established tumors. Nat Med 10:294\u2013298","journal-title":"Nat Med"},{"key":"11_CR74_11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nrc841","volume":"2","author":"S Stevanovic","year":"2002","unstructured":"Stevanovic S. (2002) Identification of tumour-associated T-cell epitopes for vaccine development. Nat Rev Cancer 2:514\u2013520","journal-title":"Nat Rev Cancer"},{"key":"11_CR75_11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1074-7613(01)00234-5","volume":"15","author":"JC Stinchcombe","year":"2001","unstructured":"Stinchcombe JC, Bossi G, Booth S, Griffiths GM. (2001) The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15:751\u2013761","journal-title":"Immunity"},{"key":"11_CR76_11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ. (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194:823\u2013832","journal-title":"J Exp Med"},{"key":"11_CR77_11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1084\/jem.20050783","volume":"203","author":"CE Tadokoro","year":"2006","unstructured":"Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC, Maraver A, Lafaille JJ, Dustin ML. (2006) Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 203:505\u2013511","journal-title":"J Exp Med"},{"key":"11_CR78_11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ni1289","volume":"7","author":"Q Tang","year":"2006","unstructured":"Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA. (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7:83\u201392","journal-title":"Nat Immunol"},{"key":"11_CR79_11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1126\/science.7678351","volume":"259","author":"SE Townsend","year":"1993","unstructured":"Townsend SE, Allison JP. (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259:368\u2013370","journal-title":"Science"},{"key":"11_CR80_11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2967\/jnumed.108.051342","volume":"49","author":"PC Tumeh","year":"2008","unstructured":"Tumeh PC, Radu CG, Ribas A. (2008) PET imaging of cancer immunotherapy. J Nucl Med 49:865\u2013868","journal-title":"J Nucl Med"},{"key":"11_CR81_11","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1084\/jem.183.4.1917","volume":"183","author":"S Valitutti","year":"1996","unstructured":"Valitutti S, Muller S, Dessing M, Lanzavecchia A. (1996) Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 183:1917\u20131921","journal-title":"J Exp Med"},{"key":"11_CR82_11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ. (2008) How regulatory T cells work. Nat Rev Immunol 8:523\u2013532","journal-title":"Nat Rev Immunol"},{"key":"11_CR83_11","first-page":"443","volume":"51","author":"IL Weissman","year":"1973","unstructured":"Weissman IL. (1973) Tumor immunity in vivo: evidence that immune destruction of tumor leaves \u201cbystander\u201d cells intact. J Natl Cancer Inst 51:443\u2013448","journal-title":"J Natl Cancer Inst"},{"key":"11_CR84_11","doi-asserted-by":"publisher","first-page":"10985","DOI":"10.1073\/pnas.0600651103","volume":"103","author":"A Wiedemann","year":"2006","unstructured":"Wiedemann A, Depoil D, Faroudi M, Valitutti S. (2006) Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. Proc Natl Acad Sci USA 103:10985\u201310990","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR85_11","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.4049\/jimmunol.163.8.4462","volume":"163","author":"H Winter","year":"1999","unstructured":"Winter H, Hu HM, Urba WJ, Fox BA. (1999) Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand. (APO-1L\/CD95L) J Immunol 163:4462\u20134472","journal-title":"(APO-1L\/CD95L) J Immunol"},{"key":"11_CR86_11","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1182\/blood-2002-12-3791","volume":"102","author":"K Wolf","year":"2003","unstructured":"Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P. (2003) Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102:3262\u20133269","journal-title":"Blood"},{"key":"11_CR87_11","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.168.9.4272","volume":"168","author":"EY Woo","year":"2002","unstructured":"Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH. (2002) Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 168:4272\u20134276","journal-title":"J Immunol"},{"key":"11_CR88_11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1517\/13543784.6.6.677","volume":"6","author":"G Yang","year":"1997","unstructured":"Yang G, Hellstrom KE, Chen L. (1997) The role of B7\u20132. (CD86) in tumour immunity. Expert Opin Investig Drugs 6:677\u2013684","journal-title":"(CD86) in tumour immunity. Expert Opin Investig Drugs"},{"key":"11_CR89_11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1084\/jem.20041684","volume":"201","author":"P Yu","year":"2005","unstructured":"Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX. (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201:779\u2013791","journal-title":"J Exp Med"},{"key":"11_CR90_11","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V","volume":"32","author":"RM Zinkernagel","year":"2002","unstructured":"Zinkernagel RM. (2002) On cross-priming of MHC class I-specific CTL: rule or exception. EurJ Immunol 32:2385\u20132392","journal-title":"EurJ Immunol"}],"container-title":["Current Topics in Microbiology and Immunology","Visualizing Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-93864-4_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T20:38:44Z","timestamp":1674074324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-540-93864-4_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540938620","9783540938644"],"references-count":90,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-93864-4_11","relation":{},"ISSN":["0070-217X"],"issn-type":[{"type":"print","value":"0070-217X"}],"subject":[],"published":{"date-parts":[[2009]]},"assertion":[{"value":"25 March 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}